This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://dx.doi.org/10.1111/
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74593979
rdf:type
wikibase:Item
schema:description
article scientifique publié en 1993 wetenschappelijk artikel scientific article published on 01 November 1993 bài báo khoa học im November 1993 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en payares de 1993 наукова стаття, опублікована в листопаді 1993
p:P577
wds:Q74593979-8349C168-061A-49A6-9A79-96FE5A628023
wdt:P577
1993-11-01T00:00:00Z
p:P2093
wds:Q74593979-9D397ADD-5363-450D-B44D-F479750344DB wds:Q74593979-133B2870-4C3A-435A-B627-91BA96EBFE47 wds:Q74593979-0014D23C-13E2-49C5-A838-2272CCAD8891 wds:Q74593979-EE962802-71D9-4B02-94B8-90026CE5179C wds:Q74593979-ED3090AB-A453-492B-A146-B8D300C8E201 wds:Q74593979-3F75E23D-6826-482A-86F6-E228311284EE wds:Q74593979-15D2153E-927A-4592-B176-0AA895426CD3 wds:Q74593979-779793CE-E902-440F-BCD7-8DD040BC8E85 wds:Q74593979-5A8ABE6B-CF4F-4B87-8CB5-1110C91E1732
wdt:P2093
J Rogers G J Coorey B S Pearson K Cox W H Watt D Raghavan E McNeil J J Grygiel A S Coates
rdfs:label
Oral cyclophosphamide for the management of hormone-refractory prostate cancer Oral cyclophosphamide for the management of hormone-refractory prostate cancer
skos:prefLabel
Oral cyclophosphamide for the management of hormone-refractory prostate cancer Oral cyclophosphamide for the management of hormone-refractory prostate cancer
schema:name
Oral cyclophosphamide for the management of hormone-refractory prostate cancer Oral cyclophosphamide for the management of hormone-refractory prostate cancer
p:P1476
wds:Q74593979-9CE3BA66-7C97-44BC-967F-0EBEC319B031
wdt:P1476
Oral cyclophosphamide for the management of hormone-refractory prostate cancer
p:P304
wds:Q74593979-84EDE463-504B-4468-8577-1BDA434ED4F4
wdt:P304
625-628
p:P31
wds:Q74593979-0E5C30AE-C277-4340-ADA0-9B2A805B2458
wdt:P31
wd:Q13442814
p:P921
wds:Q74593979-21BD6F2D-A915-4419-9344-80D415958F20
wdt:P921
wd:Q181257
p:P698
wds:Q74593979-ACE48F18-3824-425A-97F1-B353AF724DCD
wdtn:P698
n7:10071550
wdt:P698
10071550
p:P1433
wds:Q74593979-0985FA39-8CCE-460B-B613-CA7E4211E8C8
wdt:P1433
wd:Q27709789
p:P433
wds:Q74593979-54F46962-7FD2-4CF0-B6E1-5A140B00434A
p:P478
wds:Q74593979-1864043F-0E7A-4F1D-B107-AB1AFC3C3510
wdt:P433
5 Pt 1
wdt:P478
72
p:P356
wds:Q74593979-D93426F9-A805-4AE1-B1EE-2C42C5647F4F
wdtn:P356
n6:J.1464-410X.1993.TB16222.X
wdt:P356
10.1111/J.1464-410X.1993.TB16222.X